The model aims to improve health outcomes and reduce healthcare costs for people in the u.s.. The centers for medicare and medicaid services on wednesday announced that it has arrived at agreements with bluebird bio and vertex pharmaceuticals, securing their participation in a.
Government initiative designed to help improve access to gene therapies that can eliminate serious symptoms of sickle cell disease, but.. Nearly three dozen states have signed onto a u.s.